NEURALGENE
Neuralgene is a biotechnology company with the focus of developing gene therapy for Neural disorders. Neuralgene’s main development is PRCN-829, an AAV based gene therapy for the treatment of ALS. This gene therapy targets several key underlying mechanisms of ALS. This therapy is designed to target gene delivery to the brain and spinal cord. Neuralgene will be working in conjunction with Helica Labs in Playa Del Carmen, Mexico for the production of it’s gene therapy. PRCN-829 was developed ... from concepts learned with stem cell treatment of ALS. It was determined that stem cells produce substances that inhibit the process of ALS. The problem with stem cell therapy used alone, though it can be beneficial, it does not seem to have permanent lasting results. This has been shown with several different stem cell treatments in regards to ALS. PRCN-829 was developed to provide the benefits that occur with stem cell therapy, but to amplify and lengthen the effects. The effect of AAV gene therapy last for many years and may actually be lifelong.
NEURALGENE
Industry:
Biotechnology Medical
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.neuralgene.com
Status:
Active
Contact:
(251) 943-9409
Email Addresses:
[email protected]
Technology used in webpage:
Yahoo DNS Yahoo! Business Email Cybercon
Similar Organizations
3D Custom Collagen
3D Custom Collagen is a biotechnology company.
Current Employees Featured
Official Site Inspections
http://www.neuralgene.com
- Host name: cpanel302.turbify.biz
- IP address: 20.119.101.190
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Neuralgene"
Neuralgene - Crunchbase Company Profile & Funding
Neuralgene is a biotechnology company with the focus of developing gene therapy for Neural disorders. Neuralgene’s main development is PRCN-829, an AAV based gene therapy for the …See details»
Neuralgene - VentureRadar
Dansk Biotek DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in …See details»
Neuralgene - Contacts, Employees, Board Members, Advisors
About Neuralgene has 1 current employee profile, CEO and Director of R&D Jason R. Williams.Neuralgene is a biotechnology company.See details»
Neuralgene - Tech Stack, Apps, Patents & Trademarks
Neuralgene is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and CommonCrawl Top 5m.Neuralgene is a biotechnology company.See details»
Gene Therapy Developed for ALS Treatment: New …
Apr 12, 2013 About Neuralgene Neuralgene is a startup biotech company focused on AAV gene therapy, which produces multiple proteins for the …See details»
Neuralgene: Drug pipelines, Patents, Clinical trials - Synapse
Explore Neuralgene with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Endocrinology and Metabolic Disease, Nervous System Diseases ...See details»
Biotechnology Company Neuralgene Provides Hope to Children …
Apr 29, 2014 About Neuralgene Neuralgene is a biotechnology company with the main focus of developing neural-based gene therapy to treat neurodegenerative disorders.See details»
neuralgene - GitHub
People This organization has no public members. You must be a member to see who’s a part of this organization.GitHub is where neuralgene builds software.See details»
NEURALGENE LIMITED overview - Find and update company …
NEURALGENE LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»
Biotech Firm Neuralgene Begins Human Testing For New ALD …
May 1, 2014 Neuralgene announced the enrollment of the first human patient in its new genetic therapy PRCN-323 testing for rare disease adrenoleukodystrophy (ALD). …See details»
Neurogene | Developing life-changing Genetic Medicines
Neurogene is focused on developing life-changing genetic medicines for patients & families affected by rare, devastating neurological diseases.See details»
Neuralgene to start animal studies to evaluate efficacy of PRCN …
Neuralgene, a startup biotech company, will begin animal studies in May to evaluate the efficacy of PRCN-829, its new gene therapy agent for the treatment of amyotrophic lateral sclerosis …See details»
Research programme: AAV-based gene therapies - Neuralgene
Neuralgene is developing AAV-based gene therapies for the treatment of neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and Parkinson'sSee details»
Neuralgene - Crunchbase
Neuralgene and InnovATEBIO share similar industries and descriptions Save These companies are similar Geneius Natick, Massachusetts, United States 1-10 employees Biotechnology …See details»
Gene Therapy Developed for ALS Treatment: New Biotech …
Apr 12, 2013 Neuralgene's neurotropic AAV-based gene therapy platform for the treatment of neurodegenerative diseases is based on the stem cell work performed by Jason Williams, …See details»
ABCD1 gene therapy (Neuralgene) - Drug Targets, Indications
ABCD1 gene therapy (Neuralgene): a ABCD1 gene stimulants Drug, Initially developed by Neuralgene, Now, its global highest R&D status is Pending, Mechanism: ABCD1 gene ...See details»
Biotechnology Company Neuralgene Provides Hope to Children
Apr 29, 2014 Human testing is ongoing for the ALS and ALD treatments, with more extensive trials on the horizon. The company has partnered with Helica Labs in Playa del Carmen to …See details»
Biotechnology Company Neuralgene Provides Hope To Children …
Apr 29, 2014 Neuralgene is a biotechnology company with the main focus of developing neural-based gene therapy to treat neurodegenerative disorders. The company's main product is a …See details»
Biotechnology Company Neuralgene Provides Hope to Children
About Neuralgene Neuralgene is a biotechnology company with the main focus of developing neural-based gene therapy to treat neurodegenerative disorders.See details»
Human assembloid model of the ascending neural sensory pathway
Apr 9, 2025 A human ascending somatosensory assembloid model was developed, which integrates multiple organoids to simulate the spinothalamic pathway, demonstrating functional …See details»